3SBio Inc. (OTCMKTS:TRSBF) Short Interest Down 46.5% in December

3SBio Inc. (OTCMKTS:TRSBFGet Free Report) saw a large decline in short interest during the month of December. As of December 15th, there was short interest totalling 314,900 shares, a decline of 46.5% from the November 30th total of 589,100 shares. Based on an average daily trading volume, of 0 shares, the short-interest ratio is currently ∞ days.

3SBio Price Performance

TRSBF remained flat at $0.83 on Friday. 3SBio has a fifty-two week low of $0.72 and a fifty-two week high of $0.77. The stock has a 50 day moving average price of $0.74 and a 200 day moving average price of $0.75.

About 3SBio

(Get Free Report)

3SBio Inc, an investment holding company, develops, produces markets, and sells biopharmaceutical products in Mainland China and internationally. The company provides TPIAO, a recombinant human thrombopoietin to treat chemotherapy-induced thrombopenia and immune thrombocytopenia; Cipterbin, an anti-HER2 monoclonal antibody for the treatment of HER2-positive metastatic breast cancer; TNF, pre-filled aqueous injection solution.

Featured Stories

Receive News & Ratings for 3SBio Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for 3SBio and related companies with MarketBeat.com's FREE daily email newsletter.